e8vk
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 9, 2003

ORTHOLOGIC CORP.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)
     
000-21214   86-0585310
 
(Commission File Number)   (IRS Employer Identification Number)
     
1275 West Washington, Tempe, Arizona   85281
 
(Address of principal executive offices)   (Zip Code)
             
    Registrant’s telephone number, including area code:   (602) 286-5520    
       
   

Not Applicable

(Former name or former address, if changed since last report)

 

 

Item 7. Exhibits

(c)   Exhibits
         
Exhibit No.   Exhibit Description   Filed Herewith
 
 
99.1   Transcript of the conference call held by OrthoLogic Corp. on October 9, 2003   X

Item 9. Regulation FD Disclosure

     On October 9, 2003, OrthoLogic Corp. held a conference call to the discuss the announcement that it has signed a definitive agreement to sell its bone growth stimulation business to dj Orthopedics, LLC, a Delaware limited liability company and wholly-owned subsidiary of dj Orthopedics, Inc. (NYSE: DJO). The conference call was held at 12 p.m. EDT (9 a.m. Arizona time and PDT). The transcript of the conference call is filed as an Exhibit to this Report on Form 8-K.

 

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
Dated: October 9, 2003   OrthoLogic Corp.
     
    /s/ Thomas R. Trotter
   
    Thomas R. Trotter
    Chief Executive Officer

 

 

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Transcript of conference call held by OrthoLogic Corp. on October 9, 2003